ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients
- 1 October 1997
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 43 (10) , 1868-1876
- https://doi.org/10.1093/clinchem/43.10.1868
Abstract
Measurement of urokinase receptor (uPAR) in tumor extracts has prognostic value, but assay of the soluble uPAR (suPAR) in peripheral blood may offer wider applications in cancer patient management. A tumor extract uPAR ELISA was modified to eliminate nonspecific plasma protein interference, enabling specific detection of suPAR in plasma and sera with >90% recovery of added calibrator. suPAR concentrations in citrate plasma correlated with sera in 93 healthy blood donors (r = 0.84, P <0.0001), with a median value for both of 1.2 μg/L. The plasma median for 19 advanced breast cancer patients was 2.9 μg/L suPAR, and a similar increase was found for 10 advanced colon cancer patients, consistent with release of suPAR from tumors into blood. Repetitive monitoring of suPAR in cancer patients’ blood may have value in assessment of prognosis and tumor recurrence.Keywords
This publication has 27 references indexed in Scilit:
- Cell‐Surface Acceleration of Urokinase‐Catalyzed Receptor CleavageEuropean Journal of Biochemistry, 1997
- The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuriaBritish Journal of Haematology, 1995
- A cleaved form of the receptor for urokinase‐type plasminogen activator in invasive transplanted human and murine tumorsInternational Journal of Cancer, 1994
- Ligand Interaction between Urokinase-Type Plasminogen Activator and Its Receptor Probed with 8-Anilino-1-naphthalenesulfonate. Evidence for a Hydrophobic Binding Site Exposed Only on the Intact ReceptorBiochemistry, 1994
- Expression of uPA and its receptor by both neoplastic and stromal cells during xenograft invasionInternational Journal of Cancer, 1994
- A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.Journal of Clinical Investigation, 1993
- In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.The Journal of cell biology, 1991
- Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteinsBiochemistry, 1991
- Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.The Journal of cell biology, 1989
- Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibodyBiochemistry, 1982